Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monosodium alpha luminol - Bach Pharma

Next Previous
Drug Profile

Monosodium alpha luminol - Bach Pharma

Alternative Names: Galavit; GVT

Latest Information Update: 08 Jul 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator The Center of Modern Medicine (Medicor)
  • Developer Bach Pharma
  • Class Antiallergics; Antineoplastics; Antiparkinsonians; Eye disorder therapies; Phthalazines; Radioprotectives; Small molecules; Sodium compounds
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Immunological disorders
  • Registered Cancer; Female genital diseases; Inflammation
  • Phase III Breast cancer; Small cell lung cancer
  • Phase II Dry eyes; Hypersensitivity; Wounds
  • No development reported Ataxia telangiectasia; Chronic obstructive pulmonary disease; Glaucoma; Metabolic syndrome; Neurological disorders; Parkinson's disease; Radiation injuries

Most Recent Events

  • 08 Jul 2019 Chemical structure information added
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Ataxia-telangiectasia in USA (IM, Injection)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Ataxia-telangiectasia in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top